Christoffer Dahl

Christoffer Dahl currently serves as a member of the Japan Based Executive Committee at PhRMA Japan and as President and Representative Director at Genmab, overseeing the expansion of oncology and hematology operations in Japan. Previously, Christoffer held several key positions at Lundbeck, including President and Representative Director of Lundbeck Japan K.K. and Managing Director for the Nordic/Baltic region, driving P&L responsibilities and leading diverse teams across various functions. Christoffer's earlier experience includes leadership roles at GlaxoSmithKline and Coloplast A/S, alongside board membership in industry organizations. Educational qualifications include an M.Sc. in Pharmaceutical Sciences from the University of Copenhagen, along with programs at Harvard Business School and INSEAD.